Elam Nevan C

USNatural personCEO

Insider

Elam Nevan C

USNatural personCEO2 companies · 24mo

Transactions

Issuers

Buys / Sells

4/3

Last tx

02 Mar 2026

Behaviour

2 purchases reported after at least 12 months of silence — most recent on 27 Mar 2025.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Rezolute, Inc.	613,501	reported	02 Mar 2026	tx 28+25,893,618−1,319,284
Savara Inc	106,887	reported	09 Dec 2025	tx 30+309,953−195,019
NEKTAR THERAPEUTICS	85,000	reported	25 Feb 2008	tx 7+295,400−1,400

Recent transactions

Date	Type	Issuer	Qty	Price
02 Mar 2026	TAX_WITHHOLDING	Rezolute, Inc.	27,618	2.99 USD
15 Dec 2025	PURCHASE	Rezolute, Inc.	32,000	1.59 USD
09 Dec 2025	GRANT_AWARD	Savara Inc	40,000	0.00 USD
02 Dec 2025	TAX_WITHHOLDING	Savara Inc	1,473	5.81 USD
02 Dec 2025	EXERCISE	Savara Inc	5,860	1.46 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Rezolute, Inc.	613,501	reported	02 Mar 2026	tx 28+25,893,618−1,319,284
Savara Inc	106,887	reported	09 Dec 2025	tx 30+309,953−195,019
NEKTAR THERAPEUTICS	85,000	reported	25 Feb 2008	tx 7+295,400−1,400

Recent transactions

Date	Type	Issuer	Qty	Price
02 Mar 2026	TAX_WITHHOLDING	Rezolute, Inc.	27,618	2.99 USD
15 Dec 2025	PURCHASE	Rezolute, Inc.	32,000	1.59 USD
09 Dec 2025	GRANT_AWARD	Savara Inc	40,000	0.00 USD
02 Dec 2025	TAX_WITHHOLDING	Savara Inc	1,473	5.81 USD
02 Dec 2025	EXERCISE	Savara Inc	5,860	1.46 USD